Allergan Sued For Failing to Warn of Botox Side Effects
Drug maker Allergan is being sued for failing to warn users of the dangerous side effects that can result when using Botox. The products liability lawsuit was filed on behalf of over a dozen Botox users and family members that have lost loved ones from Botox use.
Some of the plaintiffs claim that receiving Botox injections left them with certain disabilities, such as numbness, vision problems, flu-like symptoms, allergic reactions, breathing problems, and muscle weakness. Deaths allegedly caused by Botox use involved a 7-year-old girl that was given Botox injections to control limb spasticity, a 69-year-old nurse that used Botox for shoulder and neck pains, and a 71-year-old woman that was administered Botox for wrinkles around her mouth. All three alleged wrongful deaths involved use of Botox in ways that federal regulators had not approved.
The lawsuit claims that injuries occurred from both non-approved and approved uses of Botox and is calling the drug “a highly legal toxin with serious and life-threatening side effects." It question’s Allergan’s promotion that Botox is a miracle drug.
While refusing to comment on the details of the dangerous drug lawsuit, an Allergan spokesperson claims that Botox has a remarkable safety record and that serious side effects are rarely reported.
Botox
Originally intended to treat people with crossed eyes, Botox is most often used for treating frown lines between the eyebrows. The Food and Drug Administration has approved the use of Botox for treating migraines.
Drug manufacturers are supposed to warn users of all potentially adverse side effects from using a particular medication or drug. When failure to provide proper warning results in injury or death, victims may be able to recover damages for personal injury or wrongful death.
Allergan failed to warn of dangerous Botox side effects, lawsuit claims, Los Angeles Times, July 10, 2008
Botox Lawsuit Claims Drug Has Fatal Flaws, WebMD.com, July 11, 2008
Related Web Resources:
